| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/PGMJ.2004.029330 |
| P8608 | Fatcat ID | release_b3vn4kaqjjdntbcqetcyhbna6i |
| P932 | PMC publication ID | 1743301 |
| P698 | PubMed publication ID | 15998815 |
| P5875 | ResearchGate publication ID | 7745111 |
| P2093 | author name string | Inoue M | |
| Tsugane S | |||
| P2860 | cites work | An ecological study on diet/nutrition and cancer in Japan | Q34431261 |
| Natural history of early gastric cancer: a non-concurrent, long term, follow up study | Q34511424 | ||
| Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population | Q34550966 | ||
| H. pylori and gastric cancer: the Asian enigma | Q34640948 | ||
| Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. | Q44889528 | ||
| EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. | Q48111201 | ||
| Effect of age on the relationship between gastric cancer and Helicobacter pylori. Tokyo Research Group of Prevention for Gastric Cancer. | Q53406282 | ||
| Pathological characteristics of gastric carcinomas in the very old. | Q55196406 | ||
| Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group | Q57268493 | ||
| Cancer incidence rates among Japanese immigrants in the city of São Paulo, Brazil, 1969-78 | Q67256213 | ||
| Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study | Q72871875 | ||
| Early carcinoma of the gastric cardia in Japan: is it different from that in the West? | Q73338917 | ||
| Is gastric carcinoma different between Japan and the United States? | Q73370159 | ||
| Clinicopathological study of gastric carcinoma in high- and low-mortality countries: Comparison between Japan and the United States | Q77951166 | ||
| Screening for gastric cancer in Japan | Q78029369 | ||
| P433 | issue | 957 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Japan | Q17 |
| epidemiology | Q133805 | ||
| P304 | page(s) | 419-424 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Postgraduate Medical Journal | Q7234294 |
| P1476 | title | Epidemiology of gastric cancer in Japan | |
| P478 | volume | 81 |
| Q93383379 | "Four-Step Procedure" of laparoscopic exploration for gastric cancer in West China Hospital: a retrospective observational analysis from a high-volume institution in China |
| Q50958892 | A Phase 1 study evaluating AMG 337 in Asian patients with advanced solid tumors. |
| Q43713510 | A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer |
| Q36275405 | A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy |
| Q36640803 | AGR2 is associated with gastric cancer progression and poor survival |
| Q34623325 | AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers |
| Q34024640 | Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer |
| Q37191333 | Adjuvant treatment for gastric cancer: chemotherapy versus radiation |
| Q46859658 | Age and sex interactions in gastric cancer incidence and mortality trends in Korea |
| Q38418462 | Age, period, and cohort effects on gastric cancer mortality |
| Q54303377 | Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway. |
| Q38986019 | Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway |
| Q36349216 | Application of artificial neural network in predicting the survival rate of gastric cancer patients |
| Q33911623 | At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. |
| Q26864277 | Aurora kinase A in gastrointestinal cancers: time to target |
| Q38058357 | Can the incidence of gastric cancer be reduced in the new century? |
| Q36986006 | Changing trends in gastrointestinal disease in the Asia-Pacific region |
| Q37155553 | Chemotherapy for metastatic gastric cancer: past, present, and future |
| Q35917089 | Chemotherapy for operable gastric cancer: current perspectives |
| Q24243598 | Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesions |
| Q35075566 | Circumstance of endoscopic and laparoscopic treatments for gastric cancer in Japan: A review of epidemiological studies using a national administrative database |
| Q36037976 | Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer |
| Q30359709 | Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases. |
| Q34494770 | Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites. |
| Q39203436 | Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa |
| Q35244568 | Clinicopathological features of gastric carcinoma in Ibadan, Nigeria, 2000-2011 |
| Q80585389 | Clinicopathological profile and long-term outcome in young adults with gastric cancer: multicenter evaluation of 214 patients |
| Q49735993 | Comparison of totally laparoscopic total gastrectomy using an endoscopic linear stapler with laparoscopic-assisted total gastrectomy using a circular stapler in patients with gastric cancer: A single-center experience |
| Q36578888 | Correlation of Helicobacter pylori and interleukin-8 mRNA expression in high risk gastric cancer population prediction. |
| Q24604411 | Critical appraisal of trastuzumab in treatment of advanced stomach cancer |
| Q55452827 | Detecting promoter methylation pattern of apoptotic genes Apaf1 and Caspase8 in gastric carcinoma patients undergoing chemotherapy. |
| Q36525600 | Digestive cancers in Morocco: Fez-Boulemane region |
| Q37141671 | Diverse eastern and Western approaches to the management of gastric cancer. |
| Q34581741 | Early gastric cancer with suspected brain metastasis arising eight years after curative resection: a case report |
| Q57072196 | Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer |
| Q50652477 | Endoscopic quality indicators for esophagogastroduodenoscopy in gastric cancer screening. |
| Q39294941 | Endoscopic submucosal dissection for gastric cancer: the influence of hospital volume on complications and length of stay. |
| Q90022339 | Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma |
| Q36507446 | Ethanol extract of paeonia suffruticosa Andrews (PSE) induced AGS human gastric cancer cell apoptosis via fas-dependent apoptosis and MDM2-p53 pathways |
| Q43563644 | Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: A prospective case control study |
| Q89208050 | Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area |
| Q55322223 | Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study. |
| Q61808902 | Expression and biological function of rhotekin in gastric cancer through regulating p53 pathway |
| Q33991617 | FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin |
| Q49892907 | Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population |
| Q36373547 | Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies |
| Q33855906 | Features of Gastric Neoplasm Detected during the Screening Examination |
| Q31165479 | Gastric Cancer Associated Genes Identified by an Integrative Analysis of Gene Expression Data. |
| Q28067574 | Gastric cancer and family history |
| Q37723251 | Gastric cancer-a clinicopathological study in a tertiary care centre of North-eastern India |
| Q43201582 | Gastric carcinoma--a big challenge in a poor economy |
| Q47673630 | Gastroduodenal Ulcers and ABO Blood Group: the Japan Nurses' Health Study (JNHS). |
| Q37841378 | Gastrointestinal cancer and brain metastasis: a rare and ominous sign |
| Q36552221 | Genetic factors involved in the development of Helicobacter pylori-related gastric cancer |
| Q28265847 | H pylori and gastric cancer: shifting the global burden |
| Q28256814 | HER2 testing in gastric cancer: a practical approach |
| Q42721433 | Health effects of human population isolation and admixture. |
| Q38052634 | Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations. |
| Q38390680 | Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings |
| Q45005362 | Hereditary factors in multiple primary malignancies associated with lung cancer |
| Q39069439 | Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study |
| Q34559419 | Human epidermal growth factor receptor 2 testing in gastric cancer: recommendations of an Asia-Pacific task force |
| Q33813676 | Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis |
| Q38072495 | Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan |
| Q35118872 | Increased microRNA-630 expression in gastric cancer is associated with poor overall survival |
| Q85001401 | Indications for staging laparoscopy in clinical T4M0 gastric cancer |
| Q24651563 | Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus |
| Q28486177 | Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis |
| Q40649709 | Is Gastric Xanthelasma an Alarming Endoscopic Marker for Advanced Atrophic Gastritis and Intestinal Metaplasia? |
| Q33790381 | Isolated non-hepatic metastasis from upper gastrointestinal adenocarcinoma: A case for surgical resection |
| Q49251764 | Knowledge Gaps among Physicians Caring for Multiethnic Populations at Increased Gastric Cancer Risk |
| Q26739046 | Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations |
| Q26774648 | Laparoscopic gastric cancer surgery: Current evidence and future perspectives |
| Q38995962 | Lentivirus-mediated knockdown of CUGBP1 suppresses gastric cancer cell proliferation in vitro |
| Q89537428 | LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis |
| Q36785925 | MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer |
| Q39770702 | Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway |
| Q82835966 | Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers |
| Q42141601 | Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer Treatment |
| Q41191668 | Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers. |
| Q38256334 | Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects |
| Q35126206 | Natural history of Helicobacter pylori infection |
| Q89037819 | New observations regarding Helicobacter pylori and gastric cancer in Mongolia |
| Q36797063 | No association between angiotensin I converting enzyme (ACE) I/D polymorphism and gastric cancer risk among Japanese |
| Q57918430 | No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese |
| Q38217426 | Observations on the epidemiology of gastrointestinal and liver cancers in the Asia-Pacific region. |
| Q34550650 | Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway |
| Q53559674 | Outcomes of patients with early gastric cancer who underwent double endoscopic intraluminal surgery. |
| Q87546741 | Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital |
| Q42863444 | Phase I study of Paclitaxel, Cisplatin and 5-fluorouracil combination chemotherapy for unresectable / recurrent gastric cancer |
| Q33407676 | Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer |
| Q33389519 | Phase II study of sunitinib as second-line treatment for advanced gastric cancer |
| Q35099892 | Polymorphisms in DNA repair genes XRCC2 and XRCC3 risk of gastric cancer in Turkey. |
| Q41085736 | Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II. |
| Q42323722 | Preliminary trial of adjuvant surgery for advanced gastric cancer |
| Q41889228 | Preliminary trial of surgery after chemotherapy for advanced gastric cancer with peritoneal dissemination |
| Q39393152 | Preoperative tumor restaging and resectability assessment of gastric cancers after chemotherapy: diagnostic accuracy of MDCT using new staging criteria. |
| Q51114391 | Prevalence and risk factors for Helicobacter pylori infection in Chinese populations. |
| Q45891830 | Prevalence and risk factors of Helicobacter pylori infection in Chinese maritime workers |
| Q80213451 | Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer |
| Q36089994 | Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer |
| Q51393573 | Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer. |
| Q39994275 | Prognostic value of tumor-related molecular expression in gastric carcinoma |
| Q64889949 | Quality of Life in Vietnamese Gastric Cancer Patients. |
| Q38047220 | Recent development of gastric cancer prevention |
| Q38218870 | Review article: the epidemiology and prevention of gastric cancer |
| Q41520182 | Robotic versus laparoscopic Gastrectomy for gastric cancer: a systematic review and updated meta-analysis |
| Q37100452 | Role of tumor necrosis factor-α -308 G/A promoter polymorphism in gastric cancer |
| Q92835307 | Routine chest CT for staging of gastric cancer |
| Q34588472 | S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial |
| Q37815444 | Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer |
| Q38711200 | Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population |
| Q81898769 | Sensitivity of ultrasonography for gastric cancer diagnosis in symptomatic patients |
| Q33830752 | Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX. |
| Q42839640 | Serum pepsinogens in gastric cancer screening |
| Q34308255 | Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent. |
| Q38127641 | Socioeconomic position and incidence of gastric cancer: a systematic review and meta-analysis |
| Q57455588 | Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants |
| Q34395983 | Standard First-Line Chemotherapy for Metastatic Gastric Cancer in Japan Has Met the Global Standard: Evidence From Recent Phase III Trials. |
| Q45981365 | Status of antioxidant enzyme: glutathione peroxidase and total polyphenol level in plasma of Tunisian patients suffering from colorectal and gastric cancer: interaction with clinical outcome. |
| Q36233013 | Synchronous lung and gastric cancers successfully treated with carboplatin and pemetrexed: a case report |
| Q41918507 | Test execution variation in peritoneal lavage cytology could be related to poor diagnostic accuracy and stage migration in patients with gastric cancer |
| Q42361146 | The Advances of Laparoscopic Gastrectomy for Gastric Cancer |
| Q38940544 | The Japanese Viewpoint on the Histopathology of Early Gastric Cancer |
| Q55069791 | The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer. |
| Q41151285 | The Prevalence of Helicobacter pylori Virulence Factors in Bhutan, Vietnam, and Myanmar Is Related to Gastric Cancer Incidence. |
| Q92218507 | The Role of Human Epidermal Growth Factor Receptor (HER2/neu) in the Prognosis of Patients with Gastric Cancer |
| Q34448490 | The optimal screening interval for gastric cancer using esophago-gastro-duodenoscopy in Japan |
| Q85790771 | The prognostic significance of p53 expression in gastric cancer: a meta-analysis |
| Q34567923 | The survival and the long-term trends of patients with gastric cancer in Shanghai, China |
| Q37633540 | Trastuzumab for gastric cancer |
| Q28732216 | Trends in population-based studies of human genetics in infectious diseases |
| Q33594943 | Use of lectin microarray to differentiate gastric cancer from gastric ulcer |
| Q40096699 | Variation in the prevalence of gastric cancer in Perú. |
| Q65001537 | Western-Type Helicobacter pylori CagA are the Most Frequent Type in Mongolian Patients. |
| Q51792005 | [Gastric stump carcinoma: frequency, treatment, complications and prognosis]. |
| Q50109094 | miR-630 inhibits epithelial-to-mesenchymal transition (EMT) by regulating Wnt/betacatenin pathway in gastric cancer cells |
Search more.